Enjoying my first #EANO2024. Thrilled to share the stage with heavy hitters Prof Helen Shih and Prof Marion Smits in the Radiation Necrosis session. Thank you @gminniti2012 for the invitation!

@SimonLo21054188 @JYangMDPhD @VenurVyshak @fredhutch Fantastic session! We had close to 100 attendees!

RT @SimonLo21054188: Feel honored to have worked with @JYangMDPhD and to be working with @VenurVyshak @fredhutch ! You guys are like CNS br…

RT @ACS4C_LiMing: We have engaged radiation oncologists, medical physicists, and implementation scientists to explore the potential of real…

RT @KrishanJethwa: 🚨🚨RTOG 0848🚨🚨 Anatomically resectable PDAC randomized postoperatively 1st randomization: Gemcitabine +/- erlotinib 🔥…

RT @SimonLo21054188: External Beam Radiation Therapy for Palliation of Symptomatic Bone Metastases: An ASTRO Clinical Practice Guideline -…

RT @feelthebyrn1: Max Heart Rate Testing & The 220-AGE Formula By @JohnHellemans David is an experienced 68-year-old runner. On the advic…

Singapore Radiological Society AGM and social night, at alumni association. Photo with the 2023 EXCO

RT @NCIS_BrainSpine: Asian Society or Neuro oncology meeting happening in Singapore Aug 2024! Please join us!

RT @ISRSy: ANNOUNCING: The next #ISRSWebinar📣 “Management of Symptomatic Brain Radiation Necrosis After Stereotactic Radiosurgery and ISRS…

RT @gminniti2012: Intetesting data... I can say one of the most important HOT TOPIC question in the management of brain mets: is combined l…

RT @NCIS_BrainSpine: We shouldn’t be saying “idk” about IDH after this talk

RT @PDBrownOnc: METIS positive randomized trial! Met Primary Endpoint Tumor Treatment fields significantly delay time to intracranial progr…

RT @Mat_Guc: Brain mets: optimal sequencing of local Tx (LT) & CNS active systemic Tx remains unkown - retrospective study of 121 pts with…

RT @GeorgeMikhaeel: Doxurubicin increases breast cancer risk independent of age or RT! 1964 pts mFU 21.6 years. Survivors treated with >200…

Engaging discussions with U of Mich team. Looking forward to cross-border collaborations! Thank you @Dan_ChangMD for visiting NCIS!

Picking an appropriate RT dose has always been arbitrary. N-of-1 personalisation is the holy grail to titrate the appropriate dose congruent with the aim of the treatment. Still a concept, but maybe reality one day @thedeanh

RT @TROGfightcancer: An important trial update at #TROGASM24 from Yu Yang Soon on the TROG 17.02 OUTRUN trial. OUTRUN is a randomised phas…

Has radiation been relegated from the management of lymphomas? Join us in this webinar to find out more on how we can mitigate toxicity @SimonLo21054188 @Rainbowmelody82 @drkevin_chua_lm

@NCIS_BrainSpine